View Author
Welte, K.
( K. Welte)
patient receptor g-csf leukemia t-all study relapse g-csf receptor response mutation blood lymphoblastic leukemia treatment neutropenia myeloid leukemia myeloid lymphoblastic fication point childhood result factor group protocol granulocyte colony-stimulating factor outcome level analysis g-csf receptors mrd-hr wild-type copyright 1995 massachusetts strati prognostic erasmus mc number mrd levels point mutation disease granulocyte product erasmu 32 d.wt cells colony-stimulating phase therapy mrd-sr t-all patients pb-all t-cell cytoplasmic maturation germany incidence aieop identi domain mrd-ir diagnosis strati fied pcr product pcr products prednisone table region marrow c-terminal cytoplasmic region figure patient 2 point mutations pcr mrd analyses wild-type receptor vector signi leukemic cells bone marrow cells expression panel induction g-csfreceptor
2 Most Recent Publications
|
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: Results of the AIEOP-BFM-ALL 2000 study
(Article)
Schrappe, M. Valsecchi, M.G. Reiter, A. Basso, G. Klingebiel, T. Messina, C. Ratei, R. Cazzaniga, G. Koehler, R. Locatelli, F. Schäfer, B.W. Aricò, M. Bartram, C.R. Welte, K. Dongen, J.J.M. van Gadner, H. Biondi, A. Conter, V. Schrauder, A. Panzer-Grümayer, R. Möricke, A. Parasole, R. Zimmermann, M. Dworzak, M.N. Buldini, B. |
2011-08-25
|
|
Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia
(Article)
Dong, F. Brynes, R.K. Tidow, N. Welte, K. Löwenberg, B. Touw, I.P. |
1995-01-01
|